PMID- 16263740 OWN - NLM STAT- MEDLINE DCOM- 20060713 LR - 20171116 IS - 0931-0509 (Print) IS - 0931-0509 (Linking) VI - 21 IP - 2 DP - 2006 Feb TI - Role of receptor for advanced glycation end-products and signalling events in advanced glycation end-product-induced monocyte chemoattractant protein-1 expression in differentiated mouse podocytes. PG - 299-313 AB - BACKGROUND: Upregulation of local monocyte chemoattractant protein-1 (MCP-1) production is involved in glomerular damage through macrophage recruitment and activation in diabetic nephropathy. Treatment of db/db mice with soluble receptor for advanced glycation end-products (RAGE) prevented recruitment of macrophages to the glomeruli and reduced albuminuria, suggesting that binding of ligands and RAGE may be involved in MCP-1 expression. Therefore, we investigated the role of advanced glycation end-products (AGEs) in MCP-1 production by podocytes and signalling events after RAGE activation. METHODS: MCP-1 gene and protein expression were examined by using reverse transcription-polymerase chain reaction and enzyme-linked immunosorbent assay in differentiated mouse podocytes. Dichlorofluorescein-sensitive intracellular reactive oxygen species (ROS) generation was measured by confocal microscopy. RAGE, phosphorylation of mitogen-activated protein kinases, nuclear factor (NF)-kappaB, c-Jun and Sp1 were studied using western blotting and immunocytochemistry. RESULTS: Both differentiated and undifferentiated podocytes expressed RAGE. MCP-1 was induced by AGEs and carboxymethyllysine (CML) in a time-dependent and dose-dependent manner in differentiated podocytes. Neutralizing antibody for RAGE suppressed AGE- and CML-induced MCP-1 production. AGEs and CML rapidly generated intracellular ROS in podocytes. Blocking of ROS by using N-acetyl-l-cysteine abolished CML and H(2)O(2)-induced MCP-1 expression. Phosphorylated extracellular signal-regulated kinase (ERK) was found in podocytes incubated with CML and was prevented by N-acetyl-l-cysteine or 7'-amino 4 [trifluoromethyl]. PD98059, an inhibitor of ERK, partially prevented CML-induced MCP-1 gene expression. NF-kappaB and Sp1 were translocated into the nucleus after podocytes were incubated with CML for 60 min. Parthenolide and mithramycin A, inhibitors of NF-kappaB and Sp1, respectively, abolished CML-induced MCP-1 gene expression in a dose-dependent manner. CONCLUSIONS: These results suggest that AGEs and CML induce MCP-1 expression in podocytes through activation of RAGE and generation of intracellular ROS. NF-kappaB and Sp1 regulate MCP-1 gene transcription. FAU - Gu, Leyi AU - Gu L AD - Department of Internal Medicine, Juntendo University School of Medicine, Tokyo, Japan. FAU - Hagiwara, Shinji AU - Hagiwara S FAU - Fan, Qiuling AU - Fan Q FAU - Tanimoto, Mitsuo AU - Tanimoto M FAU - Kobata, Mami AU - Kobata M FAU - Yamashita, Michifumi AU - Yamashita M FAU - Nishitani, Tomohito AU - Nishitani T FAU - Gohda, Tomohito AU - Gohda T FAU - Ni, Zhaohui AU - Ni Z FAU - Qian, Jiaqi AU - Qian J FAU - Horikoshi, Satoshi AU - Horikoshi S FAU - Tomino, Yasuhiko AU - Tomino Y LA - eng PT - Journal Article DEP - 20051101 PL - England TA - Nephrol Dial Transplant JT - Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association JID - 8706402 RN - 0 (Chemokine CCL2) RN - 0 (Membrane Proteins) RN - 0 (Receptor for Advanced Glycation End Products) RN - 0 (Receptors, Immunologic) SB - IM MH - Animals MH - Cell Differentiation MH - Cells, Cultured MH - Chemokine CCL2/*biosynthesis MH - Membrane Proteins/*physiology MH - Mice MH - Podocytes/cytology/*metabolism MH - Receptor for Advanced Glycation End Products MH - Receptors, Immunologic/*physiology EDAT- 2005/11/03 09:00 MHDA- 2006/07/14 09:00 CRDT- 2005/11/03 09:00 PHST- 2005/11/03 09:00 [pubmed] PHST- 2006/07/14 09:00 [medline] PHST- 2005/11/03 09:00 [entrez] AID - gfi210 [pii] AID - 10.1093/ndt/gfi210 [doi] PST - ppublish SO - Nephrol Dial Transplant. 2006 Feb;21(2):299-313. doi: 10.1093/ndt/gfi210. Epub 2005 Nov 1.